We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


CombiMatrix Expands Catalog Microarray Product Line

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "CombiMatrix Expands Catalog Microarray Product Line"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Acacia Research Corporation has announced that its CombiMatrix group has launched a series of catalog microarrays specifically designed for microRNA analysis.

Each miRNA is thought to regulate multiple genes, and since hundreds of miRNA genes are predicted to be present in higher eukaryotes the potential regulatory circuitry afforded by miRNAs is enormous.

There is evidence that miRNAs may act as key regulators of processes as diverse as early development, cell proliferation and cell death, apoptosis and fat metabolism, and cell differentiation.

"CombiMatrix's portfolio of miRNAs includes arrays that can be used in studies for human, dog, rat, mouse, and other plants and animals. This portfolio will grow throughout 2006," said Michael Tognotti, Vice President of Sales and Marketing for CombiMatrix.

"The versatility of our platform technology enables us to launch a large number of arrays and will facilitate the update of each array as new miRNA sequences are discovered. Consequently, our miRNA arrays will be the most up-to-date and comprehensive arrays available on the market."

"As we enter 2006, we plan to launch a number of new products and services, including arrays and equipment," said Dr. Amit Kumar, President and CEO of CombiMatrix.

"These products and services will address established markets as well as emerging markets including molecular diagnostics and defense applications."